The US food and drug administration (FDA) has authorized the use in emergency cases of a drug made from antibodies treated for President Donald Trump’s COVID-19.
The biotechnology company Regeneron Pharmaceuticals developed REGN-COV2 serum based on monoclonal antibodies basiliximab and imdevimab. Now it is allowed to be used to treat COVID-19 in mild to moderate severity in adults and children from 12 years old. This category also includes patients over 65 years of age and those suffering from chronic diseases.
However, the drug should not be prescribed to patients hospitalized with COVID-19 or in need of oxygen therapy.
The fact that Trump was infected with the coronavirus became known in early October. About a week later, he announced that he was cured and later promised to seek early approval for drugs that had proven positive for him: antibody serums from Regeneron Pharmaceuticals and a drug developed by Eli Lilly and Co.